CLEARWATER, Fla., April 13, 2017 /PRNewswire/ -- Acacia Diversified Holdings, Inc. ("Acacia" or the "Company") (OTCQB symbol: ACCA), an emerging cannabis company, through its wholly owned subsidiaries, MariJ Pharmaceuticals, Inc. (MariJ) and Canna-cures Research & Development Center, Inc. (Canna-Cures) focused on the development of new and proprietary medicinal products for patients, USDA certified organic mobile processing and handling solutions for its customers, and technology solutions for the expanding physician market is pleased to announce that the depository Trust Company ("DTC") has approved the Company's common stock for DWAC/FAST transfers through the company's transfer agent, Pacific Stock Transfer Company. This newly approved stock transfer capability will enable "Acacia" shareholders to transfer their shares of "Acacia" stock electronically after buying or selling on the open market, without the extra expense and delays associated with the processing and transfer of physical stock certificates.
This DTC approval should change the transactional process from weeks to hours. DWAC/FAST approval also eliminates the risk associated with the loss and replacement process of physical share certificates.
In addition to being expeditious, another side benefit is many companies approved for DWAC/FAST electronic transfers may experience higher trading volumes in their stock given the additional accessibility and availability of shares for trading.
"We are please, to share this improvement and efficient step with our shareholders," said Richard K. Pertile, Acacia's Chief Executive Officer. "Saving our shareholders cost and time, in facilitating more trading in the open market and enabling us to expand our shareholder base is paramount."
Richard K. Pertile, who has been overseeing the business of the company since January 14, 2016, states, "In addition to being DWAC/FAST eligible, I am excited to let our shareholders know our latest financial filings, the annual report on for 2016 on Form 10-K, are now available for all to review on the OTC Markets trading platform and on the company web site at: www.acaciadiversifiedholdings.com."
Statements in this press release may be "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "anticipate", "believe", "estimate", "expect", "intend" and similar expressions, as they relate to the company or its management, identify forward-looking statements. These statements are based on current expectations, estimates and projections about the company's business based, in part, on assumptions made by management. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may, and probably will, differ materially from what is expressed or forecasted in such forward-looking statements due to numerous factors. Any forward-looking statements speak only as of the date on which they are made, and the Company does not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of this release. Information on the Acacia or MariJ Pharmaceuticals websites does not constitute a part of this release.
SOURCE Acacia Diversified Holdings, Inc.